Engineered mechanosensitive MSCs enable synthetic radiotheranostic targeting across tumor types
Many cancers lack suitable molecular targets for radiotheranostics. Liu and colleagues engineer mechanosensitive MSCs that convert tumor stiffness into synthetic expression of clinically actionable targets, thereby guiding radiopharmaceuticals for PET imaging and targeted radionuclide therapy.